Key result
In advanced heart failure patients with high BNP levels, a marked improvement in exercise capacity following a 3-month exercise training program reduced the composite rate of all-cause death or HF hospitalization to 37.9% compared to 54.4% in those with poor improvement.
Why the study?
Does improvement in exercise capacity following a 3-month exercise training program improve the composite of all-cause death or heart failure hospitalization in advanced heart failure patients with high BNP levels?
Cohort (n=340)
No
Does improvement in exercise capacity following a 3-month exercise training program improve the composite of all-cause death or heart failure hospitalization in advanced heart failure patients with high BNP levels?
Absolute Event Rate: 37.9% vs 54.4%
p-value: p=0.036
In advanced heart failure patients with high BNP levels, a greater improvement in exercise capacity following a 3-month exercise training program is independently associated with more favorable long-term clinical outcomes.
Greater post-training exercise gains were associated with fewer events in advanced HF; hypothesis-generating and needs RCT confirmation.
BACKGROUND: The efficacy of exercise training (ET) programs and its relationship with long-term clinical outcomes in advanced heart failure (HF) patients with high levels of B-type natriuretic peptide (BNP) remain uncertain. METHODS AND RESULTS: was a significant independent predictor of the composite outcome and all-cause death. CONCLUSIONS: slope and more favorable long-term clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Nakanishi et al. (2017) conducted a cohort in Advanced Heart Failure with High B-Type Natriuretic Peptide Level (n=340). Exercise training (ET) program vs. Poor improvement in peak VO2 (<1.0%) was evaluated on Composite of all-cause death or HF hospitalization (p=0.036). In advanced heart failure patients with high BNP levels, a marked improvement in exercise capacity following a 3-month exercise training program reduced the composite rate of all-cause death or HF hospitalization to 37.9% compared to 54.4% in those with poor improvement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: